Filing metadata

Accession number
0000899243-21-004971
Form type
Form 5
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Feb 04, 2021
Reporting period
Dec 31, 2020
Description
Annual insider statement

Explore SEC Filings Hub